FI940167A - purine derivatives - Google Patents

purine derivatives Download PDF

Info

Publication number
FI940167A
FI940167A FI940167A FI940167A FI940167A FI 940167 A FI940167 A FI 940167A FI 940167 A FI940167 A FI 940167A FI 940167 A FI940167 A FI 940167A FI 940167 A FI940167 A FI 940167A
Authority
FI
Finland
Prior art keywords
purine derivatives
purine
derivatives
Prior art date
Application number
FI940167A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI940167A0 (en
Inventor
Lars Jacob Stray Knutsen
Jesper Lau
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI940167A0 publication Critical patent/FI940167A0/en
Publication of FI940167A publication Critical patent/FI940167A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI940167A 1992-05-14 1994-01-13 purine derivatives FI940167A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK92626A DK62692D0 (en) 1992-05-14 1992-05-14
PCT/DK1993/000158 WO1993023418A1 (en) 1992-05-14 1993-05-12 Purine derivatives

Publications (2)

Publication Number Publication Date
FI940167A0 FI940167A0 (en) 1994-01-13
FI940167A true FI940167A (en) 1994-03-03

Family

ID=8095717

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940167A FI940167A (en) 1992-05-14 1994-01-13 purine derivatives

Country Status (9)

Country Link
EP (1) EP0603348A1 (en)
JP (1) JPH06508855A (en)
AU (1) AU671995B2 (en)
CA (1) CA2113547A1 (en)
DK (1) DK62692D0 (en)
FI (1) FI940167A (en)
IL (1) IL105673A (en)
NZ (1) NZ252110A (en)
WO (1) WO1993023418A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK155292D0 (en) * 1992-12-23 1992-12-23 Novo Nordisk As CHEMICAL COMPOUNDS, THEIR PREPARATION AND USE
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
BR9507683A (en) * 1994-05-10 1997-09-23 Sandoz Ag Adenosine derivatives
EP0704215A3 (en) * 1994-06-02 1998-04-01 Takeda Chemical Industries, Ltd. Inhibitor of vascular permeability enhancer
GB9421133D0 (en) * 1994-10-20 1994-12-07 Glaxo Group Ltd Medicaments
US6110902A (en) * 1997-06-23 2000-08-29 Moehler; Hanns Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine
CO5180581A1 (en) * 1999-09-30 2002-07-30 Pfizer Prod Inc COMPOUNDS FOR THE TREATMENT OF THE ISCHEMIA PHARMACEUTICAL TIONS THAT CONTAIN THEM FOR THE TREATMENT OF THE ISCHEMIA
US6803457B1 (en) 1999-09-30 2004-10-12 Pfizer, Inc. Compounds for the treatment of ischemia
AU2001260076A1 (en) * 2000-05-15 2001-11-26 Novo-Nordisk A/S Compounds for treating disorders where a decreased level of plasma ffa is desired
US7414036B2 (en) 2002-01-25 2008-08-19 Muscagen Limited Compounds useful as A3 adenosine receptor agonists
EP2021350B1 (en) 2006-03-21 2016-12-21 Rheinische Friedrich-Wilhelms-Universität Bonn Phosphorylated a2a receptor agonists
CZ2009298A3 (en) * 2009-05-14 2010-11-24 Univerzita Palackého v Olomouci Substituted 6-benzylaminopurine ribosides, their use and pharmaceutical composition in which said compounds are comprised
CN102711771B (en) 2010-01-11 2016-05-18 伊诺泰克制药公司 Reduce combination, kit and the method for intraocular pressure
CN102933593A (en) 2010-03-26 2013-02-13 伊诺泰克制药公司 Method of reducing intraocular pressure in humans using n6-cyclopentyladenosine (cpa), cpa derivatives or prodrugs thereof
KR20130029049A (en) * 2010-03-26 2013-03-21 이노텍 파마슈티컬스 코포레이션 Adenosine compounds and their use thereof
EA027109B1 (en) 2012-01-26 2017-06-30 Инотек Фармасьютикалс Корпорейшн Anhydrous polymorphs of [(2r,3s,4r,5r)-5-(6-(cyclopentylamino)-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)]methyl nitrate and processes of preparation thereof
MX2015013234A (en) 2013-03-15 2016-04-15 Inotek Pharmaceuticals Corp Ophthalmic formulations.
JP2015172077A (en) * 2015-06-24 2015-10-01 中国医学科学院葯物研究所 Applications of n6-substituted adenosine derivative and n6-substituted adenine derivative to calming, hypnoses, convulsion resistance, epileptic resistance, parkinson disease resistance, and dementia prevention and treatment
GB2582361A (en) * 2019-03-21 2020-09-23 Univ Warwick Adenosine receptor agonists

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL128629C (en) * 1966-05-07
DE1670077C3 (en) * 1966-05-07 1975-04-24 Boehringer Mannheim Gmbh, 6800 Mannheim Adenosine derivatives and processes for their preparation
NL6717061A (en) * 1966-12-21 1968-06-24
DE2052596A1 (en) * 1970-10-27 1972-05-04 Boehringer Mannheim Gmbh, 6800 Mannheim Novel use of N (6) -substituted adenosine derivatives
DE3406533A1 (en) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim USE OF ADENOSINE DERIVATIVES AS ANTIALLERGICA AND MEDICINAL PRODUCTS CONTAINING THEM
ATE50777T1 (en) * 1984-04-18 1990-03-15 Whitby Research Inc CARDIO VASODILATORS N-6-SUBSTITUTED ADENOSINS.
US4791103A (en) * 1985-02-08 1988-12-13 Warner-Lambert Company 2,N6 -disubstituted adenosines, derivatives and methods of use
JPH0696534B2 (en) * 1986-04-25 1994-11-30 ヘキストジヤパン株式会社 Anti-dementia agent
GB8729994D0 (en) * 1987-12-23 1988-02-03 Glaxo Group Ltd Chemical compounds
HUT61567A (en) * 1990-12-07 1993-01-28 Sandoz Ag Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate
DK62592D0 (en) * 1992-05-14 1992-05-14 Novo Nordisk As

Also Published As

Publication number Publication date
EP0603348A1 (en) 1994-06-29
IL105673A (en) 1998-01-04
AU671995B2 (en) 1996-09-19
WO1993023418A1 (en) 1993-11-25
DK62692D0 (en) 1992-05-14
JPH06508855A (en) 1994-10-06
FI940167A0 (en) 1994-01-13
CA2113547A1 (en) 1993-11-25
AU4061293A (en) 1993-12-13
NZ252110A (en) 1996-07-26
IL105673A0 (en) 1993-09-22

Similar Documents

Publication Publication Date Title
ATA75293A (en) INDOLDER DERIVATIVES
DE69208877D1 (en) CHINUCLIDINE DERIVATIVES
NO922182D0 (en) CRYSTALLINIC OXATATOLAN DERIVATIVES
DK375989A (en) purine derivatives
DE69330497D1 (en) CHINAZOLIN DERIVATIVES
FI940167A0 (en) purine derivatives
FI925763A0 (en) FUNGICIDA 2-IMIDAZOLIN-5-ON-OCH 2-IMIDAZOLINE-5-THION DERIVATIVES
DE59308714D1 (en) CYCLOBUTANE-BENZENE DERIVATIVES
FI953127A (en) purine derivatives
NO952288D0 (en) Benzazepinon derivatives
FI925469A (en) Thiazolylsubstituted quinollymethoxyphenylate derivatives
DE69313890D1 (en) 5-aminoflavone derivatives
MX9206710A (en) PIRIDINOL DERIVATIVES
DK339189A (en) purine derivatives
NO964735D0 (en) Adenosine derivatives
DE59407726D1 (en) 3-aryl-4-hydroxy-3-dihydrofuranone derivatives
FI931645A0 (en) VAEXEL TILL HISSMASKIN
DE69211197D1 (en) 1-hydroxyvitamin D derivatives
KR930702353A (en) 2-carbapenem derivatives
FI245U1 (en) Takterrass till husbil
NO940123D0 (en) purine derivatives
NO932638D0 (en) 21-chloro-pregnane derivative
DE69227554D1 (en) INDOLINOSPIROBENZOPYRAN DERIVATIVES
DE69400388D1 (en) Cyclohexenediol derivatives
BR9306706A (en) Triazolyl-butane derivatives

Legal Events

Date Code Title Description
FD Application lapsed